Bioorganic & Medicinal Chemistry Letters 2012-03-15

Sesquiterpenoids from Atractylodes macrocephala act as farnesoid X receptor and progesterone receptor modulators.

Chia-Jui Tsai, Jui-Wei Liang, Hsiang-Ru Lin

Index: Bioorg. Med. Chem. Lett. 22 , 2326-2329, (2012)

Full Text: HTML

Abstract

Two sesquiterpenoids, atractylenolide II and III, were isolated and identified from Atractylodes macrocephala (Asteraceae) to be subsequently evaluated for their activity against farnesoid X receptor (FXR) and progesterone receptor (PR) by transient transfection reporter assays. These sesquiterpenoids did not exert significant agonistic effect but antagonized the activity of chenodeoxycholic acid (CDCA), an endogenous FXR agonist, for FXR driven SHP promoter transactivation. Additionally, they transactivated CYP7A1 gene promoter activity by antagonizing FXR. Apart from acting as a FXR antagonist, atractylenolide III also showed agonistic activity against PR. All these results demonstrated that atractylenolide II and III are the active components of Atractylodes macrocephala to exert specific pharmacologic effects.Copyright © 2012 Elsevier Ltd. All rights reserved.


Related Compounds

Related Articles:

Targeting of the Sonic Hedgehog pathway by atractylenolides promotes chondrogenic differentiation of mesenchymal stem cells.

2012-01-01

[Biol. Pharm. Bull. 35 , 1328-1335, (2012)]

Pharmacokinetic Profiles of Active Ingredients and Its Metabolites Derived from Rikkunshito, a Ghrelin Enhancer, in Healthy Japanese Volunteers: A Cross-Over, Randomized Study.

2015-01-01

[PLoS ONE 10 , e0133159, (2015)]

Stereospecific analytical method development and preliminary in vivo pharmacokinetic characterization of pinostrobin in the rat. Sayre CL, Zhang Y, Martinez SE, et al.

[Biomed. Chromatogr. , (2012)]

More Articles...